Related Experiment Video
Updated: Jun 1, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Uptake of Quitline Telephone Counselling by Women Who Smoke During Pregnancy
Cheryl Bailey1,2, David Ellwood1,3, Philippa Middleton1,4
1Centre of Research Excellence in Stillbirth, Mater Research Institute, The University of Queensland, Brisbane, Queensland, Australia.
Background:
While many pregnant women accept referrals for smoking cessation support, the uptake of telephone counselling appointments is unknown.
Aims:
To determine the uptake rate of Quitline appointments among Australian pregnant women who smoke after being referred by a healthcare provider.
Materials And Methods:
Data on attendance at telephone counselling appointments, number of appointments attended, gestational age at referral, referral source and smoking cessation upon completion of the program were requested from Quitline. Descriptive analysis of trends over time were undertaken using retrospective data from six Australian jurisdictions between 2016 and 2023 for pregnant women referred to Quitline by healthcare providers.
Results:
A total of 7503 pregnant women who smoke were referred to Quitline in the study period. More than half (n = 4072, 54%) did not attend any telephone counselling appointments, 24% (n = 1812) attended one appointment, 10% (n = 725) two, 5% (n = 359) three and only 7% (n = 535) attended four or more appointments. Gestational age at referral was available for 1203 women in Queensland, with 52% (n = 624) attending their first phone appointment between 1 and 20 weeks of pregnancy and 48% (n = 579) attending between 21 and 40 weeks. The overall referred smoking cessation rate in this cohort was 4% and 52% for those completing the program.
Conclusions:
The Quitline referral model for smoking cessation support for pregnant women is suboptimal. Comprehensive and consistent routinely collected data are urgently needed to monitor Quitline services for pregnant women who smoke across Australia. Further research is needed to understand the barriers to referral and uptake.
More Related Videos
05:25Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Stress Prevention and Stress Management Techniques IV
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...